FDA Inspection 796990 — RWJ Barnabas Health-Newark Beth Israel Medical Center - Blood Bank

RWJ Barnabas Health-Newark Beth Israel Medical Center - Blood Bank — FEI 2270850

The FDA completed an inspection of RWJ Barnabas Health-Newark Beth Israel Medical Center - Blood Bank on August 30, 2012 in Newark, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 30, 2012
Fiscal Year
2012
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Newark, NJ (United States)